Ensign Peak Advisors, Inc Ocular Therapeutix, Inc Transaction History

Ensign Peak Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$4.83 - $7.35 $67,716 - $103,047	14,020 Added 93.28%	29,050 $144,000
Q4 2021 Feb 11, 2022	BUY	$6.16 - $12.07 $55,624 - $108,992	9,030 Added 150.5%	15,030 $105,000
Q2 2021 Aug 13, 2021	SELL	$13.43 - $19.16 $721,338 - $1.03 Million	-53,711 Reduced 89.95%	6,000 $85,000
Q1 2021 May 12, 2021	BUY	$15.82 - $22.11 $628,228 - $878,010	39,711 Added 198.56%	59,711 $979,000
Q4 2020 Feb 12, 2021	BUY	$7.91 - $22.95 $158,200 - $459,000	20,000 New	20,000 $414,000

173

136M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $620M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.